Article

Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531

Published: Reading: 1 min

Abstract

The International Neuroblastoma Risk Group (INRG) classifier utilizes a staging system based on pretreatment imaging criteria in which image-defined risk factors (IDRFs) are used to evaluate the extent of locoregional disease. Children's Oncology Group (COG) study ANBL0531 prospectively examined institutional determination of IDRF status and compared that to a standardized central review.

Keywords

NeuroblastomaPediatric OncologyImage-defined Risk FactorsIdrf AssessmentTumor StagingDiagnostic ImagingChildren's Oncology Group

Hashtags

#Neuroblastoma#PediatricOncology#IDRF#TumorStaging

This article is published on an external journal. Click below to read the full text.

Read full article ↗
How to cite: GlobalCastMD. Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531. GlobalCastMD Medical Library. 2024-09-05. https://library.globalcastmd.com/article/9125

Comments (0)